Colorectal Neoplasms: all 5,738 studies

Page 18 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal CancerCompletedNCT03215264Phase 1Results posted
• A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal CancerCompletedNCT03206073Phase 1/2Results posted
• Comparing Interventions to Increase Colorectal Cancer ScreeningCompletedNCT03200366Not applicableResults posted
• A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid TumorsCompletedNCT03184870Phase 1/2Results posted
• A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal CancerCompletedNCT03144804Phase 2Results posted
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesCompletedNCT03126110Phase 1/2Results posted
• A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal CancerCompletedNCT03122509Phase 2Results posted
• Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRCTerminatedNCT03099486Phase 2Results posted
• Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerCompletedNCT03095781Phase 1Results posted
• Sirolimus and Familial Adenomatous Polyposis (FAP)CompletedNCT03095703Phase 2Results posted
• APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT03087591Phase 1Results posted
• Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004TerminatedNCT03050814Phase 2Results posted
• Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal CancerCompletedNCT03043313Phase 2Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.TerminatedNCT03029988Phase 1Results posted
• Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on ChemotherapyCompletedNCT03007407Phase 2Results posted
• Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal CancerCompletedNCT02981524Phase 2Results posted
• Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)TerminatedNCT02972034Phase 1Results posted
• Aspirin in Preventing Colorectal Cancer in Patients With Colorectal AdenomaActive, not recruitingNCT02965703Phase 2Results posted
• Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon CancerCompletedNCT02961374Phase 2Results posted
• Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal CancerCompletedNCT02953782Phase 1/2Results posted
• Care Coordination for Complex Cancer Survivors in an Integrated Safety Net SystemCompletedNCT02943265Not applicableResults posted
• Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal CancerTerminatedNCT02933944Phase 1Results posted
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal CancerCompletedNCT02928224Phase 3Results posted
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsCompletedNCT02903914Phase 1Results posted
• Feasibility of Home-based Preoperative Exercise in Older PeopleCompletedNCT02895464Not applicableResults posted
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung CancerActive, not recruitingNCT02888743Phase 2Results posted
• Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02873195Phase 2Results posted
• Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal CancerCompletedNCT02870920Phase 2Results posted
• Study to Increase Colorectal ScreeningCompletedNCT02870049Not applicableResults posted
• CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal CancerCompletedNCT02861300Phase 1/2Results posted
• A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRCCompletedNCT02860546Phase 2Results posted
• TAS-OX for Refractory Metastatic Colon CancerCompletedNCT02848079Phase 1/2Results posted
• De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerTerminatedNCT02842580Phase 2Results posted
• PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal CancerCompletedNCT02837263Phase 1Results posted
• Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
• Quell Opioid Reduction and Pain Relief in Patients With CancerTerminatedNCT02809846Not applicableResults posted
• Rural Interventions for Screening EffectivenessCompletedNCT02795104Not applicableResults posted
• Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]TerminatedNCT02780700Phase 2Results posted
• Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT02776683Phase 3Results posted
• Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by SurgeryCompletedNCT02754856Phase 1Results posted
• Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.CompletedNCT02754661Not applicableResults posted
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT02753127Phase 3Results posted
• A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive TherapyCompletedNCT02743221Phase 2Results posted
• Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by SurgeryTerminatedNCT02738606Phase 2Results posted
• Study to Evaluate Multiple Doses in Patients With Nasal PolyposisCompletedNCT02734849Phase 2Results posted
• S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
• Colorectal Cancer: Screening vs. Non-ScreeningCompletedNCT02727894Results posted
• Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor CancerCompletedNCT02713529Phase 1/2Results posted
• Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02713373Phase 1/2Results posted
• Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesTerminatedNCT02711137Phase 1/2Results posted
• Microparticle Enhanced Cytotoxic Transarterial Embolization TherapyCompletedNCT02694562Not applicableResults posted
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTerminatedNCT02669914Phase 2Results posted
• Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal CancerTerminatedNCT02654639Phase 2Results posted
• Phase II Study of Perindopril and Regorafenib in mCRCCompletedNCT02651415Phase 2Results posted
• Adjuvant Low Dose Aspirin in Colorectal CancerActive, not recruitingNCT02647099Phase 3Results posted
• A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal CancerCompletedNCT02613221Phase 1/2Results posted
• Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)CompletedNCT02612077Results posted
• Reducing Colorectal Cancer Death Through Mailed Outreach ScreeningCompletedNCT02584998Not applicableResults posted
• A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or RectumCompletedNCT02582970Phase 4Results posted
• Efficacy of Ginseng for Patients on RegorafenibTerminatedNCT02581059Phase 2Results posted
• Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer PatientsTerminatedNCT02568046Phase 1/2Results posted
• Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)CompletedNCT02563002Phase 3Results posted
• The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus SurgeryCompletedNCT02562924Not applicableResults posted
• CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese PopulationCompletedNCT02540850Results posted
• MEK and MET Inhibition in Colorectal CancerCompletedNCT02510001Phase 1Results posted
• FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerTerminatedNCT02508077Phase 2Results posted
• Programs To Support You During ChemotherapyCompletedNCT02489422Not applicableResults posted
• Evaluating Strategies to Present Colon Cancer Screening InformationCompletedNCT02485561Not applicableResults posted
• Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy ProcedureCompletedNCT02481219Not applicableResults posted
• Information With or Without Numbers For Optimizing Reasoning About Medical DecisionsCompletedNCT02477553Not applicableResults posted
• Regorafenib in Metastatic Colorectal CancerCompletedNCT02466009Phase 2Results posted
• Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)CompletedNCT02460198Phase 2Results posted
• Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal CancerTerminatedNCT02448810Phase 2Results posted
• Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)CompletedNCT02437136Phase 1/2Results posted
• Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer PatientsCompletedNCT02437071Phase 2Results posted
• A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal CancerTerminatedNCT02402036Phase 2Results posted
• Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCompletedNCT02394795Phase 3Results posted
• ASPirin Intervention for the REDuction of Colorectal Cancer RiskActive, not recruitingNCT02394769Not applicableResults posted
• Evaluation of the Performance of the CleanC System-IsraelCompletedNCT02387268Not applicableResults posted
• Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal CancerTerminatedNCT02384850Phase 1Results posted
• Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal CancersCompletedNCT02384759Phase 2Results posted
• AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal CancerCompletedNCT02380443Phase 2Results posted
• Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal CancerCompletedNCT02375672Phase 2Results posted
• Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02368886Phase 2Results posted
• Health Literacy Interventions to Overcome Disparities in CRC ScreeningCompletedNCT02360605Not applicableResults posted
• A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard ColonoscopyCompletedNCT02345889Not applicableResults posted
• Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedNCT02337946Phase 2Results posted
• A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)CompletedNCT02327078Phase 1/2Results posted
• Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal CancerCompletedNCT02316340Phase 2Results posted
• Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer SubjectsCompletedNCT02310464Phase 1Results posted
• Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal CancerCompletedNCT02305758Phase 2Results posted
• AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal CancerCompletedNCT02298946Phase 1Results posted
• Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNACompletedNCT02295774Phase 2Results posted
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT02292758Phase 2Results posted
• A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)CompletedNCT02291289Phase 2Results posted
• A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes?TerminatedNCT02287025Phase 4Results posted
• Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal CancerTerminatedNCT02277093Phase 2Results posted
• Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban WomenCompletedNCT02273206Not applicableResults posted
• Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.CompletedNCT02273167Phase 3Results posted

← Colorectal Neoplasms overview